Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19

Published:2024-05 Issue:5 Volume:9 Page:1244-1253
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Cheng Franco Wing Tak,Yan Vincent Ka Chun,Wan Eric Yuk Fai,Chui Celine Sze Ling,Lai Francisco Tsz Tsun,Wong Carlos King Ho,Li Xue,Zhang Irene Ran,Tang Sydney Chi Wai,Wong Ian Chi Kei,Chan Esther Wai Yin

Funder

HMRF

Publisher

Elsevier BV

Reference33 articles.

1. Factors associated with COVID-19-related death using OpenSAFELY;Williamson;Nature,2020

2. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: a systematic review and meta-analysis;Khan;J Glob Health,2020

3. Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States;Flythe;Am J Kidney Dis,2021

4. The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases;Cheng;Kidney Int,2022

5. COVID-19 in patients undergoing long-term dialysis in Ontario;Taji;CMAJ,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP